Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;72(1):58-64.
doi: 10.1002/pros.21406. Epub 2011 Apr 25.

Treatment decision-making for localized prostate cancer: what younger men choose and why

Abhinav Sidana  1 , David J Hernandez, Zhaoyong Feng, Alan W Partin, Bruce J Trock, Surajit Saha, Jonathan I Epstein
Affiliations

Treatment decision-making for localized prostate cancer: what younger men choose and why

Abhinav Sidana et al. Prostate. 2012 Jan.

Abstract

Background and objective: The literature lacks knowledge about information preferences and decision-making in young prostate cancer patients. This study provides insight into information sources consulted and factors dictating treatment decision-making in young prostate cancer patients.

Methods: Subjects were identified from pathology consult service of a National Center of Excellence. Questionnaires were mailed to 986 men, under 50 years of age, diagnosed with Gleason score 6 prostate cancer between 2001 and 2005.

Results: Four hundred ninety-three men responded. The most common primary therapies were surgery 397 (81.4%), radiation 52 (10.7%), and active surveillance (AS) 26 (5.3%). Participants with at least some college education (P = 0.003) or annual income >$100,000 (P = 0.003) were more likely to consult three or more doctors. Amongst all treatments, "doctor's recommendation" was the most influential information source, although relatively less important in the AS group. Internet was the second most frequent information source. Participants with higher education (P = 0.0003) and higher income (P = 0.002) considered sexual function more important while making a treatment choice. Only 2% of the men preferred a passive role in the decision-making. Informed decision-making was preferred more by patients who chose radiation and AS while shared decision-making was preferred more by surgery patients (P < 0.05). The majority (89%) of the respondents did not regret their decision. No difference in satisfaction levels was found between different treatment modalities.

Conclusions: This study provides insight into information sources consulted, such as the greater internet use, and various factors dictating treatment decision-making in young prostate cancer patients. There was an overall very high satisfaction rate regardless of the therapy chosen.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The most influential factors in making treatment decisions.
Fig. 2
Fig. 2
Reasons for selecting a treatment. A: Surgery versus radiation. B: Surgery versus active surveillance. C: Radiation versus active surveillance. *P < 0.05; **P < 0.01; ***P < 0.001.
See this image and copyright information in PMC

References

    1. Cegala DJ, Bahnson RR, Clinton SK, David P, Gong MC, Monk JP, III, Nag S, Pohar KS. Information seeking and satisfaction with physician-patient communication among prostate cancer survivors. Health Commun. 2008;23(1):62–69. - PubMed
    1. Berry DL, Ellis WJ, Woods NF, Schwien C, Mullen KH, Yang C. Treatment decision-making by men with localized prostate cancer: The influence of personal factors. Urol Oncol. 2003;21(2):93–100. - PubMed
    1. Steginga SK, Occhipinti S, Gardiner RA, Yaxley J, Heathcote P. Making decisions about treatment for localized prostate cancer. BJU Int. 2002;89(3):255–260. - PubMed
    1. Berry DL, Ellis WJ, Russell KJ, Blasko JC, Bush N, Blumenstein B, Lange PH. Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer. Clin Genitourin Cancer. 2006;5(3):219–226. - PubMed
    1. Holmboe ES, Concato J. Treatment decisions for localized prostate cancer: Asking men what's important. J Gen Intern Med. 2000;15(10):694–701. - PMC - PubMed